|
ASB3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.192800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.268300E-02 |
| Normal-vs-Stage2 |
2.301700E-03 |
| Normal-vs-Stage3 |
3.70020000000082E-05 |
| Normal-vs-Stage4 |
2.358400E-04 |
| Stage1-vs-Stage2 |
3.634300E-02 |
| Stage1-vs-Stage3 |
2.478600E-03 |
| Stage1-vs-Stage4 |
1.130160E-02 |
| Stage2-vs-Stage3 |
9.670200E-01 |
| Stage2-vs-Stage4 |
7.966200E-01 |
| Stage3-vs-Stage4 |
7.635000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.787710E-04 |
| Normal-vs-AfricanAmerican |
4.830400E-02 |
| Normal-vs-Asian |
3.234000E-01 |
| Caucasian-vs-AfricanAmerican |
7.213200E-01 |
| Caucasian-vs-Asian |
6.433700E-02 |
| AfricanAmerican-vs-Asian |
3.124200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.963570E-02 |
| Normal-vs-Female |
1.641240E-04 |
| Male-vs-Female |
2.983800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.048100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.68029999999942E-05 |
| Normal-vs-Age(61-80Yrs) |
1.027110E-04 |
| Normal-vs-Age(81-100Yrs) |
1.000000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.921600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.499600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.646000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.645400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.970400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.382600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.384000E-04 |
| Classical-VS-Follicular |
8.237200E-01 |
| Classical-VS-Other |
2.575400E-01 |
| Classical-VS-Normal |
5.941200E-03 |
| Tall-VS-Follicular |
1.312280E-02 |
| Tall-VS-Other |
8.741900E-02 |
| Tall-VS-Normal |
1.88430000003237E-06 |
| Follicular-VS-Other |
3.479000E-01 |
| Follicular-VS-Normal |
2.937700E-02 |
| Other-VS-Normal |
8.974200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.390500E-04 |
| Normal-vs-N1 |
9.432100E-02 |
| N0-vs-N1 |
4.903600E-01 |
|
|
